21:28 , Jul 15, 2019 |  BC Extra  |  Politics & Policy

July 15 P&P Quick Takes: Senate bills for antibiotic de-linkage, germline editing; plus site inspections and PK guidance

Senators co-sponsor antibiotic de-linkage bill  Fourteen Democratic senators introduced legislation, the Affordable Medications Act ( S. 1801 ), that includes provisions to set aside $2 billion for an Antibiotics Innovation Incentive Fund that would grant...
21:28 , Jun 25, 2019 |  BC Extra  |  Company News

WuXi AppTec raising U.S. profile to counter political attacks

WuXi AppTec plans to raise its profile in the U.S. in the hope that a better understanding of its activities will de-escalate political attacks on the company, co-CEO Edward Hu told BioCentury. While restrictions on...
00:43 , Jun 22, 2019 |  BC Extra  |  Financial News

WuXi stocks tumble as Rubio continues to press China agenda

WuXi Biologics and WuXi AppTec ended down about 6% in Hong Kong on Friday, losing a combined $765 million in market cap, as Sen. Marco Rubio (R-Fla.) continued to ratchet up pressure on China's life...
23:41 , Jun 21, 2019 |  BioCentury  |  Politics, Policy & Law

Fearmongering about China diminishes American life sciences competitiveness

No country has ever spied its way into technological superiority. The Soviet Union tried mightily and failed miserably. This lesson is relevant at a time when members of Congress are making unsubstantiated allegations about Chinese...
20:13 , Jun 20, 2019 |  BC Extra  |  Politics & Policy

Rubio wants to block U.S. military from buying drugs made in China

Sen. Marco Rubio (R-Fla.) has introduced an amendment to a defense spending bill that seeks to prevent the U.S. military by 2025 from purchasing pharmaceuticals or pharmaceutical ingredients that are made in China. The amendment...
23:45 , Jun 13, 2019 |  BC Extra  |  Politics & Policy

Rubio targets MSCI’s indexes as he ratchets up China warnings

Three days after calling for an HHS probe into CMS genetic testing payments to Chinese-linked companies, Sen. Marco Rubio (R-Fla.) has requested information from MSCI regarding its inclusion of Chinese companies in its equity indexes....
23:38 , Jun 11, 2019 |  BC Extra  |  Politics & Policy

New China regulations on genetic resources underscore flash point in U.S.-China tensions

Access to genomic data is becoming a flash point in geopolitical tensions between the U.S. and China as both sides are putting in place measures to restrict and scrutinize access to the data. As a...
00:33 , Jun 11, 2019 |  BC Extra  |  Politics & Policy

Senators call for HHS probe into CMS genetic testing payments to Chinese-linked companies

Sens. Charles Grassley (R-Iowa) and Marco Rubio (R-Fla.) have asked the HHS inspector general to investigate payments made by CMS to U.S. genetic testing companies that are partnered with companies that have ties to Beijing....
19:21 , May 6, 2019 |  BC Innovations  |  Distillery Therapeutics

Butyrate for C. difficile-induced colitis

DISEASE CATEGORY: Gastrointestinal INDICATION: Colitis Cell culture and mouse studies suggest butyrate or promotion of its synthesis could help treat Clostridium difficile -induced colitis. In human colon epithelium cells treated with supernatants from C. difficile...
19:35 , Apr 10, 2019 |  BC Innovations  |  Distillery Therapeutics

Imidazopyrimidine-based inhibitor of Leishmania proteasome identified to treat visceral leishmaniasis

DISEASE CATEGORY: Infectious disease INDICATION: Leishmaniasis Cell culture, in vitro , mouse, rat and dog studies identified an imidazopyrimidine-based inhibitor of Leishmania proteasome that could help treat visceral leishmaniasis. Chemical synthesis and screening in L....